OverviewChartTechnicalNewsTraderScreen

Ardelyx Inc/  US0396971071  /

NASDAQ
2024-04-25  10:00:00 PM Chg. -0.1200 Volume Bid11:29:00 PM Ask11:29:00 PM High Low
6.3100USD -1.87% 5.17 mill.
Turnover: 29.93 mill.		 6.3100Bid Size: 2,300 6.3700Ask Size: 900 6.4500 6.2300
GlobeNewswire 04-18 Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 03-28 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 03-25 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire 03-19 American Kidney Fund Launches Phosphorus Management Education and Awareness Campaign
GlobeNewswire 03-18 American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22
GlobeNewswire 03-15 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 03-12 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 02-29 Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire 02-27 Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
GlobeNewswire 02-22 Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 02-01 Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
GlobeNewswire 01-12 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 01-08 Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
GlobeNewswire 01-03 Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Mo...
GlobeNewswire 2023-12-20 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 2023-11-21 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 2023-11-21 Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
GlobeNewswire 2023-11-16 Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red ...
GlobeNewswire 2023-11-15 XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hype...
GlobeNewswire 2023-11-13 Ardelyx Announces Departure of Board Member
GlobeNewswire 2023-11-10 Ardelyx to Participate at the Jefferies London Healthcare Conference
GlobeNewswire 2023-11-06 Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States
GlobeNewswire 2023-11-03 Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorp...
GlobeNewswire 2023-11-02 SHAREHOLDER ALERT: Morris Kandinov Investigating ARDX, LESL, ENVX, and FATE; Shareholders are Encour...
GlobeNewswire 2023-10-31 Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenu...